These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 28349445)
21. Ureteral obstruction caused by L-asparaginase-induced pancreatitis in a child with acute lymphoblastic leukemia. Chen CH; Lu MY; Lin KH; Lin DT; Peng SF; Jou ST J Formos Med Assoc; 2004 May; 103(5):380-4. PubMed ID: 15216406 [TBL] [Abstract][Full Text] [Related]
23. L-asparaginase-induced severe necrotizing pancreatitis successfully treated with percutaneous drainage. Top PC; Tissing WJ; Kuiper JW; Pieters R; van Eijck CH Pediatr Blood Cancer; 2005 Jan; 44(1):95-7. PubMed ID: 15368548 [TBL] [Abstract][Full Text] [Related]
24. Successful Management of a Child With Drug-induced Necrotizing Pancreatitis During Acute Lymphoblastic Leukemia Therapy: A Case Report. Płotka A; Wziątek A; Wachowiak J; Derwich K J Pediatr Hematol Oncol; 2019 Mar; 41(2):e125-e128. PubMed ID: 29683955 [TBL] [Abstract][Full Text] [Related]
25. Insulin-dependent diabetes: A chronic complication to acute pancreatitis in childhood acute lymphoblastic leukemia. Wolthers BO; Mogensen PR; Frandsen TL; Abrahamsson J; Behrendtz M; Heyman M; Lohi O; Norén-Nyström U; Ruud E; Schmiegelow K Pediatr Blood Cancer; 2019 Jan; 66(1):e27437. PubMed ID: 30216644 [TBL] [Abstract][Full Text] [Related]
26. [Acute pancreatitis secondary to L-asparaginase (a case report)]. Tazi I; Rachid M; Quessar A; Harif M; Benchekroun S East Mediterr Health J; 2009; 15(2):475-9. PubMed ID: 19554997 [No Abstract] [Full Text] [Related]
27. Risk Factors for Asparaginase-associated Pancreatitis: A Systematic Review. Oparaji JA; Rose F; Okafor D; Howard A; Turner RL; Orabi AI; Byersdorfer C; Mi Q; Ritchey K; Lowe ME; Husain SZ J Clin Gastroenterol; 2017; 51(10):907-913. PubMed ID: 28375864 [TBL] [Abstract][Full Text] [Related]
28. Twenty-four hour prophylaxis with increased dosage of octreotide reduces the incidence of post-ERCP pancreatitis. Thomopoulos KC; Pagoni NA; Vagenas KA; Margaritis VG; Theocharis GI; Nikolopoulou VN Gastrointest Endosc; 2006 Nov; 64(5):726-31. PubMed ID: 17055865 [TBL] [Abstract][Full Text] [Related]
29. Clinical analysis of asparaginase-associated pancreatitis in children. Du X; Liu Z; Jia X; Wen Y; Tang Y; Xu X; Jiang M Pancreatology; 2022 Sep; 22(6):706-712. PubMed ID: 35718704 [TBL] [Abstract][Full Text] [Related]
30. Clinical and Genetic Risk Factors for Acute Pancreatitis in Patients With Acute Lymphoblastic Leukemia. Liu C; Yang W; Devidas M; Cheng C; Pei D; Smith C; Carroll WL; Raetz EA; Bowman WP; Larsen EC; Maloney KW; Martin PL; Mattano LA; Winick NJ; Mardis ER; Fulton RS; Bhojwani D; Howard SC; Jeha S; Pui CH; Hunger SP; Evans WE; Loh ML; Relling MV J Clin Oncol; 2016 Jun; 34(18):2133-40. PubMed ID: 27114598 [TBL] [Abstract][Full Text] [Related]
31. Incidence and outcome of pancreatitis in children and young adults with acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003. Samarasinghe S; Dhir S; Slack J; Iyer P; Wade R; Clack R; Vora A; Goulden N Br J Haematol; 2013 Sep; 162(5):710-3. PubMed ID: 23750892 [No Abstract] [Full Text] [Related]
32. Response to successful management of a child with asparaginase- induced hemorrhagic pancreatitis. Garrington T; Silliman CC; Bensard D; Ingram JD Med Pediatr Oncol; 1998 Aug; 31(2):127. PubMed ID: 9714616 [No Abstract] [Full Text] [Related]
33. [A case of L-asparaginase-induced severe acute pancreatitis]. Hisada S; Shiratori K; Shimizu K; Hoshino Y; Tsuchiya N; Hayashi N; Mizoguchi H Nihon Shokakibyo Gakkai Zasshi; 2001 Dec; 98(12):1374-8. PubMed ID: 11808104 [No Abstract] [Full Text] [Related]
34. Effects of delayed administration of octreotide in acute experimental pancreatitis. Kaplan O; Kaplan D; Casif E; Siegal A; Paran H; Graf E; Skornick Y J Surg Res; 1996 Apr; 62(1):109-17. PubMed ID: 8606496 [TBL] [Abstract][Full Text] [Related]
35. Somatostatin therapy in L-asparaginase-induced pancreatitis. Cheung YF; Lee CW; Chan CF; Chan KL; Lau YL; Yeung CY Med Pediatr Oncol; 1994; 22(6):421-4. PubMed ID: 7908715 [TBL] [Abstract][Full Text] [Related]
36. Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia. Earl M Clin Adv Hematol Oncol; 2009 Sep; 7(9):600-6. PubMed ID: 20020672 [TBL] [Abstract][Full Text] [Related]
37. High dose of octreotide as a prophylaxis of post-ERCP pancreatitis. Andriulli A Gastrointest Endosc; 2007 Aug; 66(2):421; author reply 421-2. PubMed ID: 17643730 [No Abstract] [Full Text] [Related]
38. [The use of Octreotide-depo for the pancreatitis' prophylaxis after radical surgery of gastric cancer with lymphadenectomy]. Chernousov AF; Egorov AV; Chernousov FA; Levkin VV; Vychuzhanin DV; Kharlov NS; Stepanov SN Khirurgiia (Mosk); 2012; (8):39-43. PubMed ID: 22968556 [TBL] [Abstract][Full Text] [Related]
39. Asparaginase-Associated Pancreatitis in Pediatric Patients with Acute Lymphoblastic Leukemia: Current Perspectives. Gibson A; Hernandez C; Tejada FNH; Kawedia J; Rytting M; Cuglievan B Paediatr Drugs; 2021 Sep; 23(5):457-463. PubMed ID: 34351604 [TBL] [Abstract][Full Text] [Related]
40. [Application of octrestatin in the treatment of patients with acute pancreatitis]. Riazanov DIu Klin Khir; 2005 Sep; (9):15-7. PubMed ID: 16445037 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]